Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Slims down for Maintainable Weight reduction - 2Ariana Grande says Eternal Sunshine 2026 tour will be her last for a 'long, long time': 'One last hurrah'
- 3Woman charged in unprovoked stabbing of tourist changing baby's diaper in Macy’s Herald Square store
- 4Tech Patterns 2023: 12 Advancements to Keep an eye Out For
- 5America's Confided in Fridge in 2024
- From Novice to Master: Dominating a Side interest
- Vote in favor of your Number one Sort of Cap
- Find the Effect of Web-based Entertainment on Society: Exploring the Computerized Scene
- Step by step instructions to Look at Compact disc Rates: A Thorough Aide
- Foreign military officials can become Israel's ambassadors, senior IDF commander tells 'Post'
- Climbing Mount Everest: An Individual Victory
- How to watch the ‘Wicked: One Wonderful Night’ special — now streaming
- Manual for Big name Work out schedules
- Famous Places to get-away for Americans
